β-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia

Diabetes

Volumn 51, Issue 1, 2002, Pages 66-72

  Biarnés, Montserrat ^a   Montolio, Marta ^a   Nacher, Victor ^b   Raurell, Mercè ^b   Soler, Joan ^b   Montanya, Eduard ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LINBITS; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIVISION; CELL LOSS; CELL VOLUME; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN TREATMENT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0036097472     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.1.66     Document Type: Article

References (43)

1. Islet mass and function in diabetes and transplantation
2. Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats
3. Critical mass of purified islets that induce normoglycemia after implantation into dogs
4. Critical mass of islets that function after implantation in a large mammalian
5. Importance of implantation site and number of islets transplanted on functional outcome following autotransplantation in a canine model
6. Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats
7. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
8. Successful islet transplantation for patients with diabetes. Fact or fantasy?
9. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol
10. Vulnerability of islets in the immediate posttransplantation period: Dynamic changes in structure and function
11. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation
12. Structural and functional changes resulting from islet isolation lead to islet cell death
13. On the variability of outcome after islet allotransplantation
14. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice
15. Effect of hypoxia on insulin secretion by isolated rat and came islets of Langerhans
16. Improved outcome of islet transplantation in insulin-treated diabetic mice: Effects on beta-cell mass and function
17. Pancreatic islet cell survival following islet isolation: The role of cellular interactions in the pancreas
18. The amelioration of hyperglycemia in streptozotocin-induced diabetic rats after the intraportal transplantation of an insufficient number of islets by nicotinamide treatment
19. Protection of mouse islet isografts from nonspecific inflamatory damage by recipient treatment with nicotin-amide and 15-deoxyspergualin
20. Prevention of primary islet isograft nonfunction in mice with pravastatin
21. Optimal insulin treatment in experimental islet transplantation
22. Normoglycemia restores β-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia
23. Linear correlation between β-cell mass and body weight throughout the lifespan in Lewis rats: Role of β-cell hyperplasia and hypertrophy
24. Point counting methods
25. The effect of predisone on pancreatic islet autografts in dogs
26. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation
27. The renal subcapsular site offers better growth conditions for transplanted mouse pancreatic islet cells than the liver or spleen
28. Apoptosis, oncosis and necrosis: An overview on cell death
29. Preserved beta cell function with insulin treatment in islet transplantation: Effect on insulin gene expression
30. Blood flow measurements in autotransplanted pancreatic islets on the rat: Impairment of the blood perfusion of the graft during hyperglycemia
31. Influence of hyperglycemia on blood perfusion of autotransplanted pancreatic islets in diabetic rats
32. Transplanted beta cell response to increased metabolic demand: Changes in beta cell replication and mass
33. Beneficial influence of glycemic control upon the growth and function of transplanted islets
34. Apoptosis contributes to the involution of β cell mass in the post partum rat pancreas
35. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis
36. Hyperglycemia-induced beta cell toxicity: The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background
37. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes
38. Long-term effects of aminoguanidine on insulin release and biosynthesis: Evidence that the formation of advanced glycosylation end products inhibits B-cell function
39. Reducing sugars triggers oxidative modification and apoptosis in pancreatic beta cells by provoking oxidative stress through the glycation reaction
40. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death
41. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice
42. Mechanisms of defective glucose-induced insulin release in human pancreatic islets transplanted to diabetic nude mice